Myxedema Coma

[ad_1] Written by: Kali Weiss, MD (NUEM ‘28) Edited by: Jackie Zewe, MD (NUEM ‘26) Expert Commentary by: Molly Estes, MD Expert Commentary The rise of GLP-1 receptor agonists like semaglutide and tirzepatide reflects a major shift in how we approach both type 2 diabetes and obesity. These medications are highly effective but come with…

Read More